Provided herein are compounds that modulate RMB39 and methods of using the compounds in RMB39-associated disorders, such as cancer (e.g., renal cell carcinoma).
Tomita,K. et al., Chemical and pharmaceutical bulletin, 1979, vol. 27, # 10, p. 2398 - 2404